Real-World Outcomes and Predictors of Response to Biologic Therapy in Moderate-to-Severe Psoriasis: A Prospective Cohort Study
Background & Objective: Psoriasis is a chronic immune-mediated inflammatory skin disease, requires long-term systemic therapy, and biologic agents are increasingly used in moderate-to-severe psoriasis. To assess clinical outcomes in the real world and ascertain predictors of response to biologic therapy in patients wit...